Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced certain preliminary, unaudited results for the quarter ended June 30, 2024, and updated full year 2024 revenue outlook. The company plans to report its complete results and host its earnings conference call for the second quarter of 2024 on August 6, 2024.
Preliminary, Unaudited Second Quarter Revenue
- Revenue for the second quarter is anticipated to be $195.9 million, a 30% increase over the same quarter of 2023
- U.S. revenue is expected to be $187.8 million, a 30% increase over the same quarter of 2023
- Revenue outside of the U.S. is expected to be $8.1 million, a 27% increase over the same quarter of 2023
Updated Full Year 2024 Revenue Guidance
- Revenue for full year 2024 is anticipated to be in the range of $788 million to $798 million, which represents growth of 26% to 28% over full year 2023. This represents a $13 million increase over initial 2024 revenue guidance range of $775 million to $785 million.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.